Russell Investments Group
RGC icon

Russell Investments Group’s Regencell Bioscience RGC Stock Holding History

Russell Investments Group’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.3K Buy
+760
New +$21.5K ﹤0.01% 3635

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Russell Investments Group's RGC Position: Q1 2026 in Review

Russell Investments Group opened a new position in Regencell Bioscience (RGC) in Q1 2026: 760 shares worth $19.3K. The stake represents ﹤0.01% of the portfolio and ranks #3635 among its holdings.

31 funds tracked by Wall St. Rank hold RGC as of Q1 2026.

  • Russell Investments Group held 760 shares of Regencell Bioscience worth $19.3K as of Q1 2026.
  • Regencell Bioscience was a new Russell Investments Group position in Q1 2026.
  • Regencell Bioscience made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3635 holding.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.